Immunotherapy for lung cancer Doctors Abroad — Page 2

Associate Professor Tahsin Ozatli specializes in treating breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• 2016 years of experience of experience in oncology
• Trained at Selcuk University Faculty of Medicine
• Former physician at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital
• Promoted to Associate Professor in 2016

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Professor Cemil Bilir brings over 21 years of experience of specialized experience in lung cancer immunotherapy at VM Medical Park Pendik Hospital.

• Board-certified in medical oncology with additional training at Cleveland Clinic
• Active member of ASCO and ESMO – stays current with latest protocols
• Currently pursuing Ph.D. in inorganic chemistry to enhance treatment approaches
• Teaches medical oncology at Sakarya University Faculty of Medicine

Specializes in immunotherapy for lung cancer at Medical Park Antalya Hospital Complex – trained at Akdeniz University, a leader in oncology.

• Board-certified in medical oncology with 20 years of experience of experience
• Extensive training at Akdeniz University, a top Turkish medical school
• Works with advanced immunotherapy protocols for lung cancer
• Member of the Turkish Medical Oncology Association

Leading expert in immunotherapy for lung cancer – Dr. Felip integrates novel immunotherapies into treatment protocols at Hospital Quiron Barcelona.

• Current member of ESMO, ASCO, and IASLC
• Received the ESMO Women for Oncology Award in 2015
• Co-chair of the 20th WCLC Congress in Barcelona
• Professor of Medicine at Universitat de Vic

Dr. Ozden specializes in medical oncology with extensive training in immunotherapy for lung cancer at Kocaeli University.

• Over 27 years of experience of experience in internal medicine and oncology
• Completed medical oncology subspecialty at Kocaeli University
• Graduated from Istanbul University's prestigious Cerrahpaşa Faculty of Medicine
• Practices at VM Medical Park Pendik Hospital

Associate Professor of Medical Oncology at İstinye University Liv Hospital Topkapı – specializes in lung cancer immunotherapy with research published in peer-reviewed journals.

• Member of American Society of Clinical Oncology (ASCO) since 2018
• Published multiple studies on lung cancer treatment outcomes
• Education Coordinator for Medical Oncology Sub-Branch
• Residency in Internal Medicine at Istanbul Şişli Hamidiye Etfal Health Application and Research Center

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Professor of Medical Oncology at Trakya University – specializes in immunotherapy for lung cancer at İstinye University Liv Hospital Topkapı.

• 29 years of experience of experience in medical oncology
• Fellowship-trained in Medical Oncology from Trakya University
• Former Associate Professor and current Professor at Trakya University
• Military service experience at Turkish Air Force Command Hospital

Specializes in immunotherapy for lung cancer at Medical Park Antalya Hospital Complex – trained in the USA and holds an Associate Professorship in Medical Oncology.

• Over 27 years of experience of experience in medical oncology
• Expert in targeted cancer therapies and next-generation genetic research
• Completed internal medicine specialization in the USA
• Associate Professor at Akdeniz University

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Assoc. Prof. Atakan Topcu specializes in immunotherapy for lung cancer at Medipol Acibadem District Hospital, with over 50 published scientific articles.

• Expert in targeted therapies and immunotherapy for solid tumors
• Member of European Society for Medical Oncology (ESMO)
• Fellowship-trained in Medical Oncology at Bezmialem Vakıf University
• Editorial Board Member for BMC Cancer journal

Assoc. Prof. Ayse Irem Yasin specializes in immunotherapy for lung cancer at Medipol Acibadem District Hospital.

• Holds an ESMO Board Certificate – a mark of excellence in oncology
• Trained at top institutions including Cleveland Clinic and Harvard Medical School
• Fellowship in Medical Oncology from Bezmialem Vakif University
• Experienced in treating various cancers including lung and breast

Assoc. Prof. Nail Paksoy specializes in immunotherapy for lung cancer at Medipol Bahçelievler Hospital, with extensive research and clinical trial experience.

• ESMO Board Certified in Medical Oncology
• Subinvestigator in multiple international lung cancer immunotherapy trials
• Published research on novel treatments for NSCLC
• Fellowship-trained in Medical Oncology at Istanbul University

Dr. Sridhar specializes in radiotherapy with advanced training in Immunotherapy for lung cancer at HCG Manavata Cancer Centre.

• Over 30 years of experience of experience in medical oncology and radiotherapy
• Diplomate of National Board in radiotherapy
• Member of the Society for Neuro-Oncology
• Part of the Bangalore Oncology Group
• Specializes in innovative cancer treatment protocols